Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -35.76M | -35.52M | -35.92M | -37.46M | -36.82M |
| Total Depreciation and Amortization | 385.00K | 387.00K | 460.00K | 538.00K | 609.00K |
| Total Amortization of Deferred Charges | 838.00K | 676.00K | 463.00K | 256.00K | 57.00K |
| Total Other Non-Cash Items | 2.71M | 2.90M | 4.36M | 4.76M | 4.87M |
| Change in Net Operating Assets | 675.00K | 1.26M | -1.09M | 868.00K | 58.00K |
| Cash from Operations | -31.15M | -30.30M | -31.72M | -31.04M | -31.22M |
| Capital Expenditure | -96.00K | -96.00K | -65.00K | -48.00K | -70.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.01M | 5.60M | 10.87M | 15.20M | 20.65M |
| Cash from Investing | 10.92M | 5.51M | 10.81M | 15.15M | 20.58M |
| Total Debt Issued | 10.36M | 10.36M | 20.36M | 20.36M | 10.46M |
| Total Debt Repaid | -1.58M | -346.00K | -413.00K | -435.00K | -521.00K |
| Issuance of Common Stock | 31.00K | 48.00K | 919.00K | 1.02M | 2.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -54.00K | -332.00K | -332.00K | -327.00K |
| Cash from Financing | 8.81M | 10.01M | 20.53M | 20.61M | 11.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.42M | -14.78M | -382.00K | 4.73M | 1.24M |